Table 1.

Demographic data of the patients.

Variables	All Patients		HRR ≤ 1.05		HRR > 1.05		p Value
	(N = 730)		(N = 603)		(N = 127)
	N	%	N	%	N	%
Age (Mean ± SD), years	67.36 ± 10.48		68.15 ± 10.37		63.58 ± 10.21		<0.00001 **
Hemoglobin (g/dL)	11.69 ± 2.03		11.11 ± 1.69		14.45 ± 0.91		<0.00001 **
RDW (%)	13.92 ± 2.04		14.17 ± 2.14		12.72 ± 0.59		<0.00001 **
Gender							<0.00001 **
Female	407	55.8	370	61.4	37	29.1
Male	323	44.2	233	38.6	90	70.9
Smoking							<0.00001 **
No	577	79	499	82.8	78	61.4
Yes	153	21	104	17.2	49	38.6
Chronic kidney disease							<0.00001 **
Stage 1 (≥90 mL/min/1.73 m2)	61	8.4	44	7.3	17	13.4
Stage 2 (60–89 mL/min/1.73 m2)	195	26.7	135	22.4	60	47.2
Stage 3 (30–59 min/1.73 m2)	294	40.3	245	40.6	49	38.6
Stage 4 (15–30 mL/min/1.73 m2)	57	7.8	57	9.5	0	0
Stage 5 (<15 mL/min/1.73 m2)	123	16.8	122	20.2	1	0.8
History of bladder cancer							0.241
No	619	84.8	507	84.1	112	88.2
Yes	111	15.2	96	15.9	15	11.8
Tumor location							0.68
Renal pelvis	319	43.7	262	43.4	57	44.9
Ureter	270	37	221	36.7	49	38.6
Synchronous	141	19.3	120	19.9	21	16.5
Approach							0.016 *
Open	358	49	308	51.1	50	39.4
Laparoscopy	372	51	295	48.9	77	60.6
Pathological T stage							0.009 **
pTa/pTis	130	17.8	108	17.9	22	17.3
pT1	173	23.7	137	22.7	36	28.3
pT2	158	21.6	134	22.2	24	18.9
pT3	221	30.3	176	29.2	45	35.4
pT4	48	6.6	48	8	0	0
Nodal status							0.252
pN0	188	25.8	158	26.2	30	23.6
pNx	492	67.4	400	66.3	92	72.4
pN1/pN2	50	6.8	45	7.5	5	3.9
Grade							0.028 *
Low	129	17.7	98	16.3	31	24.4
High	601	82.3	505	83.7	96	75.6
Focality							0.519
Unifocal	535	73.3	439	72.8	96	75.6
Multifocal	195	26.7	164	27.2	31	24.4
WBC							0.662
≤8.65 × 103 cells/μL	564	77.3	464	76.9	100	78.7
>8.65 × 103 cells/μL	166	22.7	139	23.1	27	21.3
Platelet							0.002 **
≤309 × 103 cells/μL	634	86.8	513	85.1	121	95.3
>309 × 103 cells/μL	96	13.2	90	14.9	6	4.7

HRR hemoglobin-to-red cell distribution width ratio, RDW red blood cell distribution width, WBC white blood cell, SD standard deviation, * < 0.05, ** < 0.01.